- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 114,835 | 30.07.24 20:30:35 | -12,945 | -10,13% | 114,830 | 114,860 | 125,775 | 127,780 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 109,640 | 30.07.24 20:30:34 | +0,890 | +0,82% | 109,110 | 109,670 | 109,800 | 108,750 |
